Recent progress in pancreatic cancer

By elliot k fishman, J. Herman, D. Laheru, A. Klein, M. Erdek, E. Fishman, R. Hruban. Ca, 2013

885 citations recorded by the source corpus.

Answer questions and earn CME/CNE

Subfields: Cancer Research, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/f2170c3691708e176d612c2e75b43a400771aa04

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. C. Der

In Oncology

1. C. Der

In Pulmonary and Respiratory Medicine

1. C. Der

Citations in the corpus

• Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma (2017, neutral): “Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that typically presents at an advanced stage and is refractory to most treatment modalities (Ryan et al., 2014; Wolfgang et al., 2013).”
• KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer (2018, background): “The current standards of care for PDAC consist of conventional cytotoxic drugs (Wolfgang et al. 2013).”